medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Número 3

<< Anterior

Ann Hepatol 2005; 4 (3)


Hepatic manifestations of Epstein-Barr viral infection

Méndez-Sánchez N, Aguilar-Domínguez C, Chávez-Tapia NC, Uribe M

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 205-209
Archivo PDF: 61.44 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-92.

  2. Schaller RJ, Counselman FL. Infectious mononucleosis in young children. Am J Emerg Med 1995; 13: 438-40.

  3. Hickey SM, Strasburger VC. What every pediatrician should know about infectious mononucleosis in adolescents. Pediatr Clin North Am 1997; 44: 1541-56.

  4. Devereaux CE, Bemiller T, Brann O. Ascites and severe hepatitis complicating Epstein-Barr infection. Am J Gastroenterol 1999; 94: 236-40.

  5. Mendez-Sanchez N, Uribe M. Infectious mononucleosis hepatitis: a case-report. Ann Hepatol 2004; 3: 75-76.

  6. Jimenez-Saenz M, Perez-Pozo JM, Leal-Luna A, Herrerias-Gutierrez JM. Lethal liver failure in an elderly patient with hepatitis B superinfected with Epstein-Barr virus. Eur J Gastroenterol Hepatol 2002; 14: 1283-4.

  7. Kimura H, Nagasaka T, Hoshino Y, et al. Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol 2001; 32: 757-62.

  8. Yuge A, Kinoshita E, Moriuchi M, Ohno Y, Haga H, Moriuchi H. Persistent hepatitis associated with chronic active Epstein-Barr virus infection. Pediatr Infect Dis J 2004; 23: 74-6.

  9. Nobili V, Comparcola D, Sartorelli MR, Devito R, Marcellini M. Autoimmune hepatitis type 1 after Epstein-Barr virus infection. Pediatr Infect Dis J 2003; 22: 387.

  10. Schuster VH, Muschen M. Epstein-Barr virus and the B cell: a secret romance. Trends Microbiol 2003; 11: 243-5.

  11. Rajwal S, Davison S, Wyatt J, McClean P. Primary Epstein-Barr virus hepatitis complicated by ascites with Epstein-Barr virus reactivation during primary cytomegalovirus infection. J Pediatr Gastroenterol Nutr 2003; 37: 87-90.

  12. Patel S, Zuckerman M, Smith M. Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler. J Virol Methods 2003; 109: 227-33.

  13. Hinedi TB, Koff RS. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 2003; 48: 539-41.

  14. Valentini P, Angelone DF, Miceli Sopo S, Ngalikpima CJ, Ranno O. Cholestatic jaundice in infectious mononucleosis. Minerva Pediatr 2000; 52: 303-6.

  15. Carbonero CMJ, Torronteras SR, Cintado BC. [Infectious mononucleosis: study on hospitalized children]. An Esp Pediatr 1999; 51: 664-6.

  16. Massei F, Palla G, Ughi C, Macchia P, Maggiore G. Cholestasis as a presenting feature of acute Epstein-Barr virus infection. Pediatr Infect Dis J 2001; 20: 721-2.

  17. Bernstein CN, Minuk GY. Infectious mononucleosis presenting with cholestatic liver disease. Ann Intern Med 1998; 128: 509.

  18. Mendez-Sanchez N, Chavez-Tapia NC, Espinoza B, Herrera-Gomar M, Zamora-Valdes D, Uribe M. Acute liver failure and the Molecular Adsorbents Recirculating System: early experience in a tertiary care hospital in Mexico City. Ann Hepatol 2004; 3: 164-6.

  19. Barlow G, Kilding R, Green ST. Epstein-Barr virus infection mimicking extrahepatic biliary obstruction. J R Soc Med 2000; 93: 316-8.

  20. Murray PG, Young LS. Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert Rev Mol Med 2001; 2001: 1-20.

  21. Fang CY, Chang YS, Chow KP, Yu JS, Chang HY. Construction and characterization of monoclonal antibodies specific to Epstein-Barr virus latent membrane protein 1. J Immunol Methods 2004; 287: 21-30.




2020     |     www.medigraphic.com